Dentistry

Missing teeth predict cardiovascular events

Advanced tooth loss often indicates that a person has a history of inflammatory oral diseases. In an extensive cohort study, it was shown that tooth loss associate with future cardiovascular events, diabetes and death. The ...

Cardiology

Visit-to-visit LDL-C variability predicts cardiac event risk

(HealthDay)—Visit-to-visit variability in low-density lipoprotein cholesterol (LDL-C) can independently predict cardiovascular events in individuals with coronary artery disease, according to a study published in the April ...

Cardiology

Study shows who benefits most from statins

New research suggests that widely used statin therapy provides the most benefit to patients with the highest genetic risk of heart attack. Using a relatively straightforward genetic analysis, the researchers assessed heart ...

Cardiology

What's more effective: Generic or brand-name statins?

Statins are the most frequently prescribed drugs in the United States and are effective in reducing cardiovascular events. However, evidence suggests that patients do not always take these medications as prescribed and may ...

Cardiology

Beta-blockers in new onset CHD reduce cardiac risk only post-MI

(HealthDay)—Use of beta-blockers among patients with new-onset coronary heart disease (CHD) appears to lower risk of cardiac events only among patients with a recent myocardial infarction (MI), according to a study published ...

Cardiology

Higher operator volume linked to better PCI outcomes

(HealthDay)—Higher individual operator percutaneous coronary intervention (PCI) volume is associated with better outcomes, according to a review published online June 17 in Circulation: Cardiovascular Quality and Outcomes.

Cardiology

Many at high cardiovascular risk still not on statins

(HealthDay)—Many individuals at high risk for cardiovascular events, such as those with coronary artery disease, diabetes, or both, are not receiving statins, according to research published in the May/June issue of the ...

Cardiology

Darapladib falls short in chronic coronary heart disease

The novel inflammation inhibitor darapladib showed no primary-endpoint advantage over placebo in patients with chronic coronary heart disease treated with a high level of background care, although it did suggest possible ...

Cardiology

Long term exposure to air pollution linked to coronary events

Long term exposure to particulate matter in outdoor air is strongly linked to heart attacks and angina, and this association persists at levels of exposure below the current European limits, suggests research conducted at ...

page 6 from 18